Andrea Schlegel, MD
Surgery · Cleveland, OHNPI 1285328880
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.9%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Bridge To Life Ltd accounts for 87.9% of it on its own, with 5 other manufacturers making up the rest. Among surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $1756.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bridge To Life Ltd$39K
- Organox Ltd$3K
- Histosonics, Inc.$1K
- Xvivo Perfusion Inc.$385
- Organ Recovery Systems, Inc.$298
- Solventum Corporation$44
What the payments were for
- Consulting fees$18,50042%
- Speaking & faculty fees$3,2007%
- Travel & lodging$20,17246%
- Food & beverage$2,0325%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bridge To Life Ltd | 12 | $38,582 |
| Organox Ltd | 3 | $3,348 |
| Histosonics, Inc. | 5 | $1,247 |
| Xvivo Perfusion Inc. | 2 | $385 |
| Organ Recovery Systems, Inc. | 1 | $298 |
| Solventum Corporation | 2 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- METRA$3,348
- XVIVO Perfusion System (XPS)$332
How this compares
$43,904 in reported general payments places this provider in the 95th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other surgery in Cleveland
- Raymond OndersCleveland$1.2M
- Neilendu KunduCleveland$808K
- Chase WehrleCleveland$741K
- Craig JarrettCleveland$622K
- Ihya GorgunCleveland$527K
- Gareth Morris-StiffCleveland$250K
- Alan SaberCleveland$204K
- Eren BerberCleveland$191K
- Leena KhaitanCleveland$187K
- Ali AminianCleveland$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.